Prof Peter Josef Ell

Prof Peter Josef EllTel: 020 3447 0555
Fax: 020 7436 0603
Email: peter.ell@uclh.nhs.uk

Location:
University College Hospital

Specialities:
Nuclear medicine

Professional background

  • FMedSci , Dr H.C.,  AΩA  MD, MSc ,PD ,FRCR ,FRCP
  • National Institute Health Research (NIHR)  Senior Investigator 2008-2011
  • UCLH NHS Trust Consultant Physician
  • Emeritus Professor UCL
  • Trustee University College London Hospitals Charity

Research interests

  • Molecular Imaging and Nuclear Medicine

Publications

F18 FDG PET and PETCT in the Evaluation of Cancer Treatment Response. Ben-Haim,S and Ell,PJ. Journal of Nuclear Medicine 50, 88-99, 2009
Idiopathic Pulmonary Fibrosis and Diffuse Parenchymal Lung Disease : Implications from Initial Experience with  F18PETCT.
Groves,AM,Win,Th,Screaton,NJ,Berovic,M,Endozo,R,Booth,H,Kayani,I,Menezes,LJ,Dickson,JC abd Ell,PJ. Journal of  Nuclear Medicine, 50,538-545,2009
Functional imaging of Neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 112(11):2447-55.,2008
Sugar rush: the early days of molecular imaging. Ell PJ Lancet Oncology., 9(4), 400, 2008.

Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.  Du Y, Cullum I, Illidge T and Ell PJ.   Journal of Clinical Oncology, 10, 3440-3447, 2007.

Non F18 FDG In Clinical Oncology.  Groves A, Win T, Ben-Haim S and Ell PJ. Lancet Oncology  8, 822-830, 2007

The impact of 18F-FDG PET/CT in patients with liver metastases. Chua SC, Groves
AM, Kayani I, Menezes L, Gacinovic S, Du Y, Bomanji J and Ell PJ. European Journal of Nuclear Medicine 12, 1906-1914, 2007

Safety and Efficacy of Repeat Administration of Samarium Sm-153 Lexidronam to Patients With Metastatic Bone Pain. Sartor O, Reid RH, Bushnell DL, Quick DP, Ell PJ.  Cancer, 109, 637-643, 2007.

Dose escalation study of Rhenium-186-HEDP in the treatment of patients with in-operable osteosarcoma. Syed R, Waddington W, Cassoni A, Kayani I, Groves AM, Ell PJ, Bomanji J.  Journal of Nuclear Medicine 47, 1927-35, 2006.

186Re-HEDP in the Treatment of Patients with Inoperable Osteosarcoma.  Syed R, Bomanji J, Nagabhushan  N, Kayani I, Groves AM, Waddington WA, Cassoni A and Ell PJ.  The Journal of Nuclear Medicine, 47(12) 1927-1935, 2006.

Randomized multicenter trial of sentinel node biopsy in breast cancer: The Almanac Trial.  Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D and Ell PJ.  Journal of the National Cancer Institute, 98, 599-609, 2006.

GMC/GDC number: 2473453